BEACON EMR HIPAA Disclaimer Site Map Social Media
BayCare Health System
Community Benefit Financial Assistance Policy Quality Report Card Health Library News Doctor Connect Find Us
Services Hospitals Find A Doctor Classes & Events About Us Careers Contact Us Get E-Newsletter
HealthDay Articles & Information
 Back  Back


May We Help You?
 

Call 1-877-692-2922
Monday-Friday, 8am to 5pm

Persons with hearing and speech disabilities can reach the above number through TDD and other specialized equipment by calling the Florida Relay Service at 711.

Contact Us
Send 
e-mail
Search jobs


Decrease (-) Restore Default Increase (+) Font Size
Print    Email
Search Health Information   

FDA Approves Botox for Crow's Feet

However, cosmetic improvement is only temporary

WEDNESDAY, Sept. 11 (HealthDay News) -- Adults bothered by the appearance of crow's feet -- lines at the outside corners of the eyes -- have a new treatment option.

The U.S. Food and Drug Administration on Wednesday approved the use of Botox Cosmetic for temporary improvement of moderate to severe crow's feet.

Botox Cosmetic (onabotulinum toxin A) has been approved in the United States since 2002 to treat frown lines between the eyebrows. It works to make wrinkles less prominent by keeping facial muscles from tightening, according to an FDA news release.

"This additional indication will provide people with a new FDA-approved treatment option for those seeking a smoother appearance by temporarily minimizing the appearance of crow's feet at the sides of the eyes," Dr. Susan Walker, director of the division of dermatology and dental products in the FDA's Center for Drug Evaluation and Research, said in the news release.

Botox Cosmetic is given by intramuscular injection. Treatment for frown lines (officially known as glabellar lines) and crow's feet (lateral canthal lines) is given at the same time.

The treatment underwent two clinical trials to establish its safety and effectiveness for improving crow's feet. In all, 833 adults with moderate to severe lines were randomly assigned to get Botox Cosmetic or an inactive placebo. Participants in the Botox Cosmetic group showed greater improvement in their appearance.

Eyelid edema -- in which the eyelids are swollen and contain excessive fluid -- was the most common side effect reported.

Botox Cosmetic is manufactured by Allergan Inc., based in Irvine, Calif.

More information

Visit the U.S. National Library of Medicine to learn more about Botox.


SOURCE: U.S. Food and Drug Administration, news release, Sept. 11, 2013

Copyright © 2013 HealthDay. All rights reserved.


Serving The Tampa Bay Area © Copyright 2014 BayCare Health System